EUVIMEDEUVIMED entdecken
Multizentrische Studie

Hypertension Medication Changes in Patients Prescribed Remote Monitoring

Calvin J Winkler iD, Lucia C Petito iD, Yaw Peprah iD, Ji Young Lee, Hironori Sato iD, Stephen D Persell iD

American Journal of Hypertension · 2025

DOI: 10.1093/ajh/hpaf228 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Hypertension, 2025. Verfasst von Calvin J Winkler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Feinberg School of Medicine, Northwestern University, Chicago, IL, United States. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Blood Pressure Monitoring, Ambulatory, Blood Pressure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Northwestern University, Omron Healthcare Co. Ltd, Northwestern University by Omron Healthcare Co. Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Remote patient monitoring (RPM) includes home blood pressure (BP) measurement with readings sent directly to the electronic health record (EHR). We hypothesize that RPM facilitates quicker, more frequent, more appropriate antihypertensive medication changes.

Methods

Patients with hypertension in 6 primary care clinics were prescribed RPM between November 2020 and August 2021 (N = 288) and matched to 4 control patients (N = 1152). Office and RPM BP readings and medication data over 18 months were extracted from the EHR. RPM patients were classified as baseline-controlled (office and RPM <130/<80 mmHg), sustained (office and RPM ≥130 and/or ≥80), white-coat (office ≥130 and/or ≥80, RPM <130/<80), or masked hypertension (office <130/<80, RPM ≥130 and/or ≥80).

Results

RPM patients had earlier first antihypertensive medication changes, with half of RPM patients having ≥1 change by 228 days versus 530 days for controls. RPM patients had more total medication changes, with 25% of RPM patients having ≥4 (median 1; 25th-75th percentiles 0-4) changes versus ≥2 (median 1; 0-2) changes in controls. Compared to baseline sustained hypertension RPM users, white-coat hypertension users were less likely to have ≥1 medication increase (24% [N = 11] versus 53% [N = 74], P = .001) within 12 months. Compared to baseline-controlled RPM users, masked hypertension users were less likely to have ≥1 medication decrease (0% [N = 0] versus 44% [N = 8]; P = .003) within 12 months.

Conclusions

Even without additional staff dedicated to medication adjustment, RPM facilitated quicker medication changes, more total changes, and differential prescribing decisions for white-coat and masked hypertension patients supporting RPM use in primary care. Clinical trial registration number ClinicalTrials.gov identifier: NCT05562921.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsHypertensionBlood Pressure Monitoring, AmbulatoryBlood PressureMasked HypertensionHumansFemaleMaleMiddle AgedAgedElectronic Health RecordsTime FactorsTelemedicinePrimary Health CareWhite Coat HypertensionTreatment Outcome

Stichwörter der Autor:innen

blood pressurehypertensionprimary careremote physiological monitoringtelemedicine

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Division of Biostatistics and Informatics, Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Division of General Internal Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Data Analytics Department, Technology Development HQ, Omron Healthcare, Co., Ltd., Kyoto, Japan.
  • Center for Primary Care Innovation, Institute for Public Health and Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.

ORCID-Profile: Calvin J Winkler, Lucia C Petito, Yaw Peprah, Hironori Sato, Stephen D Persell

Förderung

  • Northwestern University
  • Omron Healthcare Co. Ltd
  • Northwestern University by Omron Healthcare Co. Ltd

Zitieren

APA

Winkler, C. J., Petito, L. C., Peprah, Y., Lee, J. Y., Sato, H., & Persell, S. D. (2025). Hypertension Medication Changes in Patients Prescribed Remote Monitoring. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf228

Vancouver

Winkler CJ, Petito LC, Peprah Y, Lee JY, Sato H, Persell SD. Hypertension Medication Changes in Patients Prescribed Remote Monitoring. American Journal of Hypertension. 2025. doi:10.1093/ajh/hpaf228

BibTeX
@article{Winkler2025,
  author = {Winkler, Calvin J and Petito, Lucia C and Peprah, Yaw and Lee, Ji Young and Sato, Hironori and Persell, Stephen D},
  title = {Hypertension Medication Changes in Patients Prescribed Remote Monitoring},
  journal = {American Journal of Hypertension},
  year = {2025},
  doi = {10.1093/ajh/hpaf228}
}
Kostenlos starten →